Race Oncology Limited (RAONF)
OTCMKTS · Delayed Price · Currency is USD
1.220
0.00 (0.00%)
At close: Jul 11, 2024

Race Oncology Company Description

Race Oncology Limited, a clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.

The company’s lead product is bisantrene, a small molecule chemotherapeutic that has a clinical history with demonstrated therapeutic benefits in adult and paediatric patients.

It is advancing reformulated bisantrene (RC220) to address the unmet need of patients across various oncology indications with a clinical focus on anthracycline combination to deliver cardioprotection and enhanced anticancer activity in solid tumors.

The company is also exploring RC220 as a low intensity treatment for acute myeloid leukaemia. In addition, it is investigating the effect of bisantrene on the m6A RNA pathway, following independent research identifying bisantrene as the potent inhibitor of fat mass and obesity-associated protein.

The company has collaborations with Astex, City of Hope, MD Anderson, Sheba City of Health, UNC School of Medicine, University of Wollongong, and University of Newcastle.

The company was formerly known as Coronado Resources Limited. Race Oncology Limited was incorporated in 2011 and is headquartered in Sydney, Australia.

Race Oncology Limited
Country Australia
Founded 2011
Industry Biotechnology
Sector Healthcare
CEO Daniel Tillett

Contact Details

Address:
Gateway, 1 Macquarie Place
Sydney, 2000
Australia
Phone 61 2 8051 3043
Website raceoncology.com

Stock Details

Ticker Symbol RAONF
Exchange OTCMKTS
Fiscal Year July - June
Reporting Currency AUD
ISIN Number AU000000RAC3
SIC Code 2836

Key Executives

Name Position
Dr. Daniel Tillett Chief Executive Officer, Managing Director and Director
Dr. Peter M. Smith Ph.D. Executive Chairman
Dr. Michelle Rashford Chief Medical Officer
Brendan Brown Chief Financial Officer
Dr. Sophia Moscovis Vice President of Operations and Strategy
Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D. Company Secretary